Skip to main content

News Archive

News Archive - School of Medicine

Protein’s Impact on Colorectal Cancer is Dappled

June 30, 2015

Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the third leading cause of cancer-related death in the United States. A key protein in the pathway also appears to be predictive of cancer survival rates.

At the Nexus of Substance Abuse and HIV

June 30, 2015

Dan Werb, PhD, an internationally noted epidemiologist at University of California, San Diego School of Medicine, has been named one of four inaugural recipients of the Avenir Award, a prestigious $1.5 million research grant from the U.S. National Institute on Drug Abuse, part of the National Institutes of Health (NIH).

Dean Will Head Organization Matching Medical Students with Residency Programs

June 29, 2015

The National Resident Matching Program (NRMP) Board of Directors has appointed Maria C. Savoia, MD, dean of Medical Education at University of California, San Diego School of Medicine, as board chair of the nonprofit organization that oversees the medical resident matching process nationwide.

Braking Mechanism Identified for Cell Growth Pathway Linked to Several Cancers

June 26, 2015

Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.

Two UC San Diego Researchers to Lead Alzheimer’s Disease Cooperative Study

June 25, 2015

Two of the nation’s leading physician-scientists in the search to better understand and treat Alzheimer’s disease – William Mobley, MD, PhD, and Michael Rafii, MD, PhD – have been named interim co-directors of the Alzheimer’s Disease Cooperative Study (ADCS), a major initiative formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California, San Diego.

Multiple Pathways Progressing to Alzheimer’s Disease

June 25, 2015

UC San Diego School of Medicine researchers report that the amyloid cascade hypothesis, long believed to describe the pathology of Alzheimer’s disease, is not a fixed and invariable sequence of events. Rather, early indicators or biomarkers of the neurodegenerative condition vary by individual, making preclinical diagnoses more challenging.

Jill P. Mesirov Appointed Associate Vice Chancellor for Computational Health Sciences

June 24, 2015

Leading computational biologist Jill P. Mesirov, PhD, has been appointed associate vice chancellor for computational health sciences and professor of medicine at University of California, San Diego School of Medicine and Moores Cancer Center. Mesirov most recently served as associate director and chief informatics officer at the Broad Institute of MIT and Harvard, where she directed the Computational Biology and Bioinformatics Program.

New Biomarker Identified in Women with Mental Illness

June 19, 2015

Psychiatric disorders can be difficult to diagnose because clinicians must rely upon interpreted clues, such as a patient’s behaviors and feelings. For the first time, researchers at University of California, San Diego School of Medicine report identifying a biological marker: the over-production of specific genes that could be a diagnostic indicator of mental illness in female psychiatric patients.

Single Enzyme’s Far-Reaching Influence in Human Biology and Disease

June 18, 2015

Researchers at University of California, San Diego School of Medicine have made a surprisingly simple discovery: The modification of more than 100 secreted proteins is the work of a single enzyme called Fam20C. The finding is published June 18 by Cell.

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment

June 17, 2015

Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs before they begin treatment, researchers at University of California, San Diego School of Medicine conducted a proof-of-principle study with a small group of metastatic colorectal cancer patients. The results revealed two genes that could help physicians make more informed treatment decisions for patients with this disease.
Category navigation with Social links